Metastatic Squamous Neck Cancer With Occult Primary  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00005035: Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Completed
2
US
oxaliplatin
Ohio State University Comprehensive Cancer Center, National Cancer Institute (NCI)
Head and Neck Cancer
 
03/04
NCT00448552: Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Completed
2
30
US
capecitabine, oxaliplatin
University of Miami
Head and Neck Cancer
04/07
06/08
NCT00503997: Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Completed
2
42
US
oxaliplatin, Eloxatin, pemetrexed disodium, Alimta
Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI)
Head and Neck Cancer
06/09
06/10

Download Options